With the increasing use of flow diversion as treatment for intracranial aneurysms, there is a concomitant increased vigilance in monitoring complications. The low porosity of flow diverters is concerning when the origins of vessels are covered, whether large circle of Willis branches or critical perforators. In this study, the authors report their experience with flow diverter coverage of the lenticulostriate vessels and evaluate their safety and outcomes.
The authors retrospectively reviewed 5 institutional databases of all flow diversion cases from August 2012 to June 2018. Information regarding patient presentation, aneurysm location, treatment, and outcomes were recorded. Patients who were treated with flow diverters placed in the proximal middle cerebral artery (MCA), proximal anterior cerebral artery, or distal internal carotid artery leading to coverage of the medial and lateral lenticulostriate vessels were included. Clinical outcomes according to the modified Rankin Scale were reviewed. Univariate and multivariate analyses were performed to establish risk factors for lenticulostriate infarct.
Fifty-two patients were included in the analysis. Postprocedure cross-sectional images were available in 30 patients. Two patients experienced transient occlusion of the MCA during the procedure; one was asymptomatic, and the other had a clinical and radiographic ipsilateral internal capsule stroke. Five patients had transient symptoms without radiographic infarct in the lenticulostriate territory. Two patients experienced in-stent thrombosis, leading to clinical MCA infarcts (one in the ipsilateral caudate) after discontinuing antiplatelet therapy. Discontinuation of dual antiplatelet therapy prior to 6 months was the only variable that was significantly correlated with stroke outcome (p < 0.01, OR 0.3, 95% CI 0–0.43), and this significance persisted when controlled for other risk factors, including age, smoking status, and aneurysm location.
The use and versatility of flow diversion is increasing, and safety data are continuing to accumulate. Here, the authors provide early data on the safety of covering lenticulostriate vessels with flow diverters. The authors concluded that the coverage of these perforators does not routinely lead to clinically significant ischemia when dual antiplatelet therapy is continued for 6 months. Further evaluation is needed in larger cohorts and with imaging follow-up as experience develops in using these devices in more distal circulation.
Correspondence Peter Kan: Baylor College of Medicine, Houston, TX. firstname.lastname@example.org.INCLUDE WHEN CITING Published online January 11, 2019; DOI: 10.3171/2018.8.JNS18755.Disclosures Dr. Thomas: support of non–study-related clinical or research effort from Stryker. Dr. Mokin: consultant for Penumbra, Inc. Dr. Puri: consultant for Stryker Neurovascular and Medtronic; direct stock ownership in InNeuroCo; and support of non–study-related clinical or research effort from Stryker Neurovascular and Metronic.
AdeebN, GriessenauerCJ, ForemanPM, MooreJM, ShallwaniH, Motiei-LangroudiR, : Use of platelet function testing before Pipeline Embolization Device placement: a multicenter cohort study. 48:1322–1330, 201710.1161/STROKEAHA.116.01530828411263)| false
ColbyGPBenderMTLinLMBeatyNHuangJTamargoRJ: Endovascular flow diversion for treatment of anterior communicating artery region cerebral aneurysms: a single-center cohort of 50 cases. J Neurointerv Surg9:679–6852017
DaiD, DingYH, KadirvelR, RadAE, LewisDA, KallmesDF: Patency of branches after coverage with multiple telescoping flow-diverter devices: an in vivo study in rabbits. 33:171–174, 201210.3174/ajnr.A2879)| false
HahnemannMLRingelsteinASandalciogluIEGoerickeSMoenninghoffCWankeI: Silent embolism after stent-assisted coiling of cerebral aneurysms: diffusion-weighted MRI study of 75 cases. J Neurointerv Surg6:461–4652014
KallmesDFBrinjikjiWCekirgeSFiorellaDHanelRAJabbourP: Safety and efficacy of the Pipeline embolization device for treatment of intracranial aneurysms: a pooled analysis of 3 large studies. J Neurosurg127:775–7802017
KallmesDF, BrinjikjiW, CekirgeS, FiorellaD, HanelRA, JabbourP, : Safety and efficacy of the Pipeline embolization device for treatment of intracranial aneurysms: a pooled analysis of 3 large studies. 127:775–780, 20172779151910.3171/2016.8.JNS16467)| false
KallmesDF, HanelR, LopesD, BoccardiE, BonaféA, CekirgeS, : International retrospective study of the pipeline embolization device: a multicenter aneurysm treatment study. 36:108–115, 20152535581410.3174/ajnr.A4111)| false
MazurMD, KilburgC, WangV, TausskyP: Pipeline embolization device for the treatment of vertebral artery aneurysms: the fate of covered branch vessels. 8:1041–1047, 201610.1136/neurintsurg-2015-01204026491041)| false
SafainMGRoguskiMHellerRSMalekAM: Flow diverter therapy with the Pipeline Embolization Device is associated with an elevated rate of delayed fluid-attenuated inversion recovery lesions. Stroke47:789–7972016
SafainMG, RoguskiM, HellerRS, MalekAM: Flow diverter therapy with the Pipeline Embolization Device is associated with an elevated rate of delayed fluid-attenuated inversion recovery lesions. 47:789–797, 201610.1161/STROKEAHA.115.01052226903583)| false
SoedaASakaiNMuraoKSakaiHIharaKYamadaN: Thromboembolic events associated with Guglielmi detachable coil embolization with use of diffusion-weighted MR imaging. Part II. Detection of the microemboli proximal to cerebral aneurysm. AJNR Am J Neuroradiol24:2035–20382003
SoedaA, SakaiN, MuraoK, SakaiH, IharaK, YamadaN, : Thromboembolic events associated with Guglielmi detachable coil embolization with use of diffusion-weighted MR imaging. Part II. Detection of the microemboli proximal to cerebral aneurysm. 24:2035–2038, 200314625228)| false
SzikoraIBerenteiZKulcsarZMarosfoiMVajdaZSLeeW: Treatment of intracranial aneurysms by functional reconstruction of the parent artery: the Budapest experience with the pipeline embolization device. AJNR Am J Neuroradiol31:1139–11472010
SzikoraI, BerenteiZ, KulcsarZ, MarosfoiM, VajdaZS, LeeW, : Treatment of intracranial aneurysms by functional reconstruction of the parent artery: the Budapest experience with the pipeline embolization device. 31:1139–1147, 201010.3174/ajnr.A202320150304)| false
VedantamARaoVYShaltoniHMMawadME: Incidence and clinical implications of carotid branch occlusion following treatment of internal carotid artery aneurysms with the pipeline embolization device. Neurosurgery76:173–1782015
VedantamA, RaoVY, ShaltoniHM, MawadME: Incidence and clinical implications of carotid branch occlusion following treatment of internal carotid artery aneurysms with the pipeline embolization device. 76:173–178, 201510.1227/NEU.000000000000059525549190)| false
YavuzK, GeyikS, SaatciI, CekirgeHS: Endovascular treatment of middle cerebral artery aneurysms with flow modification with the use of the pipeline embolization device. 35:529–535, 201410.3174/ajnr.A369224072620)| false
YeungTWLaiVLauHYPoonWLTanCBWongYC: Long-term outcome of endovascular reconstruction with the Pipeline embolization device in the management of unruptured dissecting aneurysms of the intracranial vertebral artery. J Neurosurg116:882–8872012
YeungTW, LaiV, LauHY, PoonWL, TanCB, WongYC: Long-term outcome of endovascular reconstruction with the Pipeline embolization device in the management of unruptured dissecting aneurysms of the intracranial vertebral artery. 116:882–887, 201210.3171/2011.12.JNS11151422264186)| false